Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |